Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|54|4|1398-1409

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.54, Iss.4, 2011-10, pp. : 1398-1409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 372-380

Karger

Access to resources Recommend Favorite

Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 2, 2018-01 ,pp. : 374-387

John Wiley & Sons Inc

Access to resources Recommend Favorite

Growth arrest and DNA damage‐inducible 34 regulates liver regeneration in hepatic steatosis in mice

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1343-1356

John Wiley & Sons Inc

Access to resources Recommend Favorite

Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 930-941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Signaling Pathways in Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 18-23

Karger

Access to resources Recommend Favorite